Search

Your search keyword '"Taillé, Camille"' showing total 511 results

Search Constraints

Start Over You searched for: Author "Taillé, Camille" Remove constraint Author: "Taillé, Camille"
511 results on '"Taillé, Camille"'

Search Results

1. Anti–IL-4R versus anti–IL-5/5R after anti–IL-5/5R failure in asthma: An emulated target trial

2. Exploring Definitions and Predictors of Response to Biologics for Severe Asthma

3. CT Imaging Assessment of Response to Treatment in Allergic Bronchopulmonary Aspergillosis in Adults With Bronchial Asthma

5. Evidence-Based Guideline for the diagnosis and management of eosinophilic granulomatosis with polyangiitis

7. Analysis of comorbidities and multimorbidity in adult patients in the International Severe Asthma Registry

8. A role for IL-33-activated ILC2s in eosinophilic vasculitis

10. Impact of Initiating Biologics in Patients With Severe Asthma on Long-Term Oral Corticosteroids or Frequent Rescue Steroids (GLITTER): Data From the International Severe Asthma Registry

11. French recommendations for the diagnosis and management of lymphangioleiomyomatosis

12. Severe Asthma Standard-of-Care Background Medication Reduction With Benralizumab: ANDHI in Practice Substudy

13. Long-term safety and efficacy of tezepelumab in people with severe, uncontrolled asthma (DESTINATION): a randomised, placebo-controlled extension study

17. Anti-IL-4R versus Anti-IL-5/5R after Anti-IL-5/5R failure in asthma: an emulated target trial

19. Global Variability in Administrative Approval Prescription Criteria for Biologic Therapy in Severe Asthma

22. Allergen Immunotherapy for the Prevention and Treatment of Asthma.

25. Severe asthma care trajectories: the French RAMSES cohort

26. Reply to “Exploring the long-term effects of biologic initiation in severe asthma: Insights from the International Severe Asthma Registry”

28. CT Imaging Assessment of Response to Treatment in Allergic Bronchopulmonary Aspergillosis in Adults With Bronchial Asthma

31. Residual ground glass opacities three months after Covid-19 pneumonia correlate to alteration of respiratory function: The post Covid M3 study

33. The Genetics of Interstitial Lung Diseases

34. Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial

39. Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial

41. Bevacizumab in addition to standard of care did not shorten the time to improve hypoxemia in severe hypoxemic COVID-19 pneumonia in a prospective randomized controlled trial.

42. High-dose aspirin in severe uncontrolled asthma associated with chronic rhinosinusitis with nasal polyps (CRwNP) : the ASTHMIRINE trial

43. Is telomere length a predictor of long-term survival in patients with COVID-19 pneumonia?

47. Digital Action Plan (Web App) for Managing Asthma Exacerbations: Randomized Controlled Trial

49. Dupilumab for relapsing or refractory sinonasal and/or asthma manifestations in eosinophilic granulomatosis with polyangiitis: a European retrospective study.

Catalog

Books, media, physical & digital resources